Isodiol International Company Description
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States.
It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds.
The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products.
It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products.
The company is headquartered in Vancouver, Canada.
| Country | Canada |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Marcos Agramont |
Contact Details
Address: 200 Granville Street Vancouver, British Columbia V6C 1S4 Canada | |
| Phone | 604 409 4409 |
| Website | isodiol.com |
Stock Details
| Ticker Symbol | ISOLF |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | CAD |
| ISIN Number | CA46500L2003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Marcos Agramont | Chief Executive Officer and Director |
| Patrick Edward Ogle J.D., L.L.M. | Chief Operating Officer and Director |
| Marvin Washington | Vice President and Director of Business Development and Director |
| Soheil Samimi | Advisor |
| Andrew Stanton Alvis | President, Interim Chief Financial Officer and Director |
| Kevin W. Swadish | Chief Revenue Officer |